Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with persistent asthma, diagnosed according to GINA 2010 guideline and who additionally meet the following criteria:
Patients who are receiving ICS treatment in a stable regimen for ≥ 4 weeks
Patients with a pre-bronchodilator FEV1 value of ≥ 40% and ≤ 80% of predicted normal value
Patients who demonstrate an increase of \>= 12% and 200 mL in FEV1
ACQ-5 score ≥ 1.5
You may not be if
Patients who are current smokers or have a smoking history of greater than 10 pack years (defined as the number of packs of 20 cigarettes smoked per day multiplied by number of years the patient smoked).
Patients with chronic lung disease, including COPD, pulmonary tuberculosis, bronchiectasis, sarcoidosis, interstitial lung disease and cystic fibrosis.
Patients with any chronic conditions affecting the respiratory tract (e.g., chronic sinusitis) which in the opinion of the investigator may interfere with the study evaluation or optimal participation in the study.
